China Pharma Holdings (CPHI) Return on Capital Employed Growth (5y) (2016 - 2026)
China Pharma Holdings (CPHI) Return on Capital Employed Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | China Pharma Holdings | 39.71 Mn | 39.41 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,662.00 |
| Dec 31, 2025 | 629.00 |
| Sep 30, 2025 | 15,065.00 |
| Jun 30, 2025 | 13,093.00 |
| Mar 31, 2025 | 13,820.00 |
| Dec 31, 2024 | 4,697.00 |
| Sep 30, 2024 | -2,127.00 |
| Jun 30, 2024 | -1,005.00 |
| Mar 31, 2024 | -134.00 |
| Dec 31, 2023 | -342.00 |
| Sep 30, 2023 | 412.00 |
| Jun 30, 2023 | -1,215.00 |
| Mar 31, 2023 | -1,862.00 |
| Dec 31, 2022 | -5,135.00 |
| Sep 30, 2022 | -5,606.00 |
| Jun 30, 2022 | -1,666.00 |
| Mar 31, 2022 | -1,449.00 |
| Dec 31, 2021 | -1,765.00 |
| Sep 30, 2021 | -2,400.00 |
| Jun 30, 2021 | -3,757.00 |